Cite
APA Citation
Xu, W., Feng, R., Wang, L., Song, Y., Zhu, H., Fan, L., Guo, X., Wei, X., Lin, N., Xu, C., Wang, Z., Xiao, X., Shen, Y., Chen, Y., Chen, Y., Tan, F., Anthony, S. P., & Li, J. (n.d.). p684: PHASE 1 STUDY OF LP-108, A SELECTIVE BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA. HemaSphere, 6, 580–581. http://access.bl.uk/ark:/81055/vdc_100158013638.0x000005